Assessment of immunogenicity and efficacy of a Zika vaccine using modified vaccinia Ankara virus as carriers
Zika virus (ZIKV) is an emerging mosquito-borne flavivirus that has spread to more than 70 countries worldwide since 2015. Despite active research, there are currently no licensed vaccines or therapeutics. We have previously reported the development of various adenoviral vectored vaccine candidates...
Автори: | López-Camacho, C, Kim, Y, Abbink, P, Larocca, R, Huiskonen, J, Barouch, D, Reyes-Sandoval, A |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
MDPI
2019
|
Схожі ресурси
Схожі ресурси
-
Assessment of Immunogenicity and Efficacy of a Zika Vaccine Using Modified Vaccinia Ankara Virus as Carriers
за авторством: César López-Camacho, та інші
Опубліковано: (2019-11-01) -
Safety and immunogenicity of DNA/modified vaccinia virus ankara malaria vaccination in African adults.
за авторством: Moorthy, V, та інші
Опубліковано: (2003) -
New approaches for improving the immunogenicity of modified vaccinia virus Ankara as a recombinant vaccine vector
за авторством: Alharbi, N
Опубліковано: (2014) -
Clinical development of Modified Vaccinia virus Ankara vaccines.
за авторством: Gilbert, S
Опубліковано: (2013) -
Clinical development of Modified Vaccinia virus Ankara vaccines
за авторством: Gilbert, S
Опубліковано: (2013)